Show simple item record

dc.creatorNational Institutes of Health [NIH] (United States). Recombinant DNA Advisory Committee. Human Gene Therapy Subcommitteeen
dc.date.accessioned2011-07-12T18:38:49Zen
dc.date.available2011-07-12T18:38:49Zen
dc.date.created1986-12en
dc.date.issued1986-12en
dc.identifier.bibliographicCitationRecombinant DNA Technical Bulletin 1986 December; 9(4): 221-242en
dc.identifier.urihttp://hdl.handle.net/10822/540375en
dc.formatArticleen
dc.languageengen
dc.source69296en
dc.subjectGene Therapyen
dc.subject.classificationGene Therapy / Gene Transferen
dc.subject.classificationHuman Experimentation Policy Guidelines / Institutional Review Boardsen
dc.subject.classificationSocial Control of Human Experimentationen
dc.titlePoints to consider in the design and submission of human somatic-cell gene therapy protocolsen
dc.provenanceDigital citation created by the Bioethics Research Library, Georgetown University, for the National Information Resource on Ethics and Human Genetics, a project funded by the United States National Human Genome Research Instituteen
dc.provenanceDigital citation migrated from OpenText Livelink Discovery Server database named GenETHX to DSpace collection GenETHX hosted by Georgetown Universityen


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2022 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885